The new Food, Conservation and Energy Act of 2008 will reorganize the US Department of Agriculture’s (USDA) $2 billion worth of research programs. The extramural Cooperative State Research, Education and Extension Service will be renamed the National Institute for Food and Agriculture (NIFA). For making competitive grants, NIFA will replace the National Research Initiative (NRI) […]
Chinese pharmaceuticals could drive down the price of generic drugs. According to IMS Health, the US Department of Agriculture’s (USDA) approval last year of Zhejiang Huahi Pharmaceutical’s generic form of Nevirapine, an AIDS drug, indicates a trend. IMS reports that at least 10 other Chinese companies are bringing generics to market, with some appearing as […]
Basel, Switzerland 5/27/08—Lonza has acquired amaxa, a supplier of nucleic acid transfection systems and consumables, for an undisclosed amount. Amaxa will join the Cell Discovery business of Lonza Bioscience and its headquarters in Cologne, Germany, will become a new product development site for the Cell Discovery business. “With this acquisition Lonza further strengthens its position […]
Recent data suggests that scientists from past Eastern-bloc countries that are now EU members are increasing their use of the EU’s funding programs, such as the €12.5 billion ($27.1 billion) Seventh Framework Program (FP7), which extends from 2007 to 2013. During the Soviet era, these countries’ universities and research institutes were kept apart and grants […]
France’s research minister, Valerie Pecresse, announced on May 21 that France’s main research agency, the Centre National de la Recherhe Scientifique (CNRS), will be split into six specialized institutes. They will focus on mathematics, physics, chemistry, engineering sciences, social sciences and ecology. The remaining sectors will be supervised by existing agencies: INSERM will take over […]
Santa Clara, CA 5/7/08—Agilent Technologies has acquired the assets of Dowpharma’s Nucleic Acid Medicine business. The purchase is part of Agilent’s expansion of its Nucleic Acid Solutions Division, which offers therapeutic nucleic acid development services and manufacturing solutions. “Agilent will have the ability to serve customers from preclinical through large-scale commercial launch with facilities, equipment […]
In standard X-ray diffraction (XRD), an X-ray source illuminates the sample and characteristic diffraction patterns are formed due to the constructive interference of X-rays diffracting from the sample’s atoms. In particular, crystalline samples create sharp diffraction patterns due to the crystal lattice’s regular spacing of atoms. The mathematical relation that governs this process, Bragg’s Law, […]
Atomic force microscopy’s (AFM) advent at the start of the semiconductor boom provided the technology an introduction into the private sector, but AFM’s potential is still being discovered. Park Systems specializes in AFM systems for research and industrial applications. AFM both measures and provides an image of a sample’s surface with subnanometer resolution by running […]
The 2007 IBO Executive Compensation Survey includes 57 executives from 42 companies and is based upon the companies currently in IBO’s three Stock Indexes (see IBO 4/30/08) and Becton Dickinson. QIAGEN, Nanometrics and Starlims are excluded as a result of incomplete filings. To create the tables, IBO selected one or two executives for each company […]
In the first quarter of 2008, revenues for IBO’s Laboratory Instrument Sales Index grew 11.4% to $4,557 million. Operating profit jumped 14.3% to $758 million, and operating margin climbed 40 basis points to 16.6% of sales. Acquisitions and favorable currency effects continue to positively impact revenue growth and operating results, particularly for companies such as […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
